Literature DB >> 29335475

Discontinuous ventilator weaning of patients with acute SCI.

Wout Füssenich1,2, Sven Hirschfeld Araujo3, Birgitt Kowald4, Allard Hosman5, Marc Auerswald3, Roland Thietje3.   

Abstract

STUDY
DESIGN: Retrospective, single centre cohort study.
OBJECTIVES: To determine factors associated with ventilator weaning success and failure in patients with acute spinal cord injury (SCI); determine length of time and attempts required to wean from the ventilator successfully and determine the incidence of pneumonia.
SETTING: BG Klinikum Hamburg, Level 1 trauma centre, SCI Department, Germany.
METHODS: From 2010 until 2017, 165 consecutive patients with cervical SCI, initially dependent on a ventilator, were included and weaned discontinuously via tracheal cannula. Data related to anthropometric details, neurological injury, respiratory outcomes, and weaning parameters were prospectively recorded in a database and retrospectively analysed.
RESULTS: Seventy-nine percent of all patients were successfully weaned from ventilation. Average duration of the complete weaning process was 37 days. Ninety-one percent of the successfully weaned patients completed this on first attempt. Age (>56 years), level of injury (C4 and/or above), vital capacity (<1500 ml), obesity (>25 kg/m2), and chronic obstructive pulmonary disease (COPD) significantly decreased the chance of successful weaning. These factors also correlated with a higher number of weaning attempts. High level of injury, older age, and reduced vital capacity also increased the duration of the weaning process. Patients with low vital capacity and concurrent therapy with Baclofen and Dantrolene showed higher rates of pneumonia.
CONCLUSIONS: We conclude that mentioned factors are associated with weaning outcome and useful for clinical recommendations and patient counselling. These data further support the complexity of ventilator weaning in the SCI population due to associated complications, therefore we recommend conducting weaning of patients with SCI on intensive or intermediate care units (ICU/IMCU) in specialised centres.

Entities:  

Mesh:

Year:  2018        PMID: 29335475     DOI: 10.1038/s41393-017-0055-x

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  31 in total

1.  Diaphragm ultrasonography to estimate the work of breathing during non-invasive ventilation.

Authors:  Emmanuel Vivier; Armand Mekontso Dessap; Saoussen Dimassi; Frederic Vargas; Aissam Lyazidi; Arnaud W Thille; Laurent Brochard
Journal:  Intensive Care Med       Date:  2012-04-05       Impact factor: 17.440

2.  International standards for neurological classification of spinal cord injury (revised 2011).

Authors:  Steven C Kirshblum; Stephen P Burns; Fin Biering-Sorensen; William Donovan; Daniel E Graves; Amitabh Jha; Mark Johansen; Linda Jones; Andrei Krassioukov; M J Mulcahey; Mary Schmidt-Read; William Waring
Journal:  J Spinal Cord Med       Date:  2011-11       Impact factor: 1.985

3.  Baclofen pump intervention for spasticity affecting pulmonary function.

Authors:  Deanna Britton; Barry Goldstein; Jill Jones-Redmond; Peter Esselman
Journal:  J Spinal Cord Med       Date:  2005       Impact factor: 1.985

4.  Diaphragm dysfunction assessed by ultrasonography: influence on weaning from mechanical ventilation.

Authors:  Won Young Kim; Hee Jung Suh; Sang-Bum Hong; Younsuck Koh; Chae-Man Lim
Journal:  Crit Care Med       Date:  2011-12       Impact factor: 7.598

5.  Weaning from mechanical ventilation.

Authors:  J-M Boles; J Bion; A Connors; M Herridge; B Marsh; C Melot; R Pearl; H Silverman; M Stanchina; A Vieillard-Baron; T Welte
Journal:  Eur Respir J       Date:  2007-05       Impact factor: 16.671

6.  [Epidemiology, diagnosis and treatment of adult patients with nosocomial pneumonia. S-3 Guideline of the German Society for Anaesthesiology and Intensive Care Medicine, the German Society for Infectious Diseases, the German Society for Hygiene and Microbiology, the German Respiratory Society and the Paul-Ehrlich-Society for Chemotherapy].

Authors:  K Dalhoff; M Abele-Horn; S Andreas; T Bauer; H von Baum; M Deja; S Ewig; P Gastmeier; S Gatermann; H Gerlach; B Grabein; G Höffken; W V Kern; E Kramme; C Lange; J Lorenz; K Mayer; I Nachtigall; M Pletz; G Rohde; S Rosseau; B Schaaf; R Schaumann; D Schreiter; H Schütte; H Seifert; H Sitter; C Spies; T Welte
Journal:  Pneumologie       Date:  2012-12-06

7.  Using an evidence-based protocol to guide rehabilitation and weaning of ventilator-dependent cervical spinal cord injury patients.

Authors:  Charles J Gutierrez; Jeffrey Harrow; Fred Haines
Journal:  J Rehabil Res Dev       Date:  2003 Sep-Oct

8.  Predictors of ventilator weaning in individuals with high cervical spinal cord injury.

Authors:  Anthony E Chiodo; William Scelza; Martin Forchheimer
Journal:  J Spinal Cord Med       Date:  2008       Impact factor: 1.985

9.  The Effectiveness of Early Tracheostomy (within at least 10 Days) in Cervical Spinal Cord Injury Patients.

Authors:  Hoi Jung Choi; Sung Hwa Paeng; Sung Tae Kim; Kun Su Lee; Moo Sung Kim; Yong Tae Jung
Journal:  J Korean Neurosurg Soc       Date:  2013-09-30

10.  Changing demographics of spinal cord injury over a 20-year period: a longitudinal population-based study in Scotland.

Authors:  E J McCaughey; M Purcell; A N McLean; M H Fraser; A Bewick; R J Borotkanics; D B Allan
Journal:  Spinal Cord       Date:  2015-10-13       Impact factor: 2.772

View more
  2 in total

1.  Respiratory morbidity and mortality of traumatic cervical spinal cord injury at a level I trauma center in India.

Authors:  Deep Sengupta; Ashish Bindra; Niraj Kumar; Keshav Goyal; Pankaj Kumar Singh; Arvind Chaturvedi; Rajesh Malhotra; Ashwani Kumar Mishra
Journal:  Spinal Cord Ser Cases       Date:  2021-05-13

Review 2.  Systematic Review of Incidence Studies of Pneumonia in Persons with Spinal Cord Injury.

Authors:  Anja Maria Raab; Gabi Mueller; Simone Elsig; Simon C Gandevia; Marcel Zwahlen; Maria T E Hopman; Roger Hilfiker
Journal:  J Clin Med       Date:  2021-12-31       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.